Neurodegenerative Disorders Flashcards

1
Q

When neurons die can they be replaced?

A

No when neurons die they cannot be replaced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name two neurodegenerative disease that causes death of neurons

A

-Alzheimer’s disease
-Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which neurodegenerative diseases are responsible for protein folding

A

-Alzheimer’s disease
-Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which protein is folded in Parkinson’s disease

A

a(Alpha )synuclein (mutations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which protein is misfolded in Alzheimer’s disease

A

-Beta-amyloid protiens(AB)
-Tau proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe mechanism of protein misfolding and how it causes pathology

A

-first genetic mutation leads to misfolding of proteins which can form and insoluble aggregate which gets deposited intracellular and extra cellular
-leading to neurotoxicity which is demonstrated by excitotoxicity ,oxidative stress and apoptosis and necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the chief symptoms of Parkinson’s disease

A

-Bradykinesia
-muscle rigidity and when movement starts it cannot stop as well as initiate
-Tremor at rest
-cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathogenesis of Parkinson’s disease

A

Gradual loss of dopamine when the striatal dopamine content has fallen 20-40 % of normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Parkinson’s disease is associated with what conditions

A

-dementia
-depression
-autonomic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the mechanisms of action of Parkinson’s drug treatment

A

-you reduce the release of acetylcholine in striatum by increasing dopaminergic effects
-you block the NMDA receptors to inhibit release of acetylcholine
-Lastly you reduce acetylcholine by Muscarinic receptor antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

So in essence the drugs for Parkinson’s is classified into

A

*Dopaminomimetics
-NDMA receptor antagonist
-central Muscarinic cholinergic antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List drugs for treatment of Parkinson’s disease

A

-levodopa with combination of carbidopa and as well as entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Parkinson’s drugs mention 2 drugs that are dopamine agonists

A

-Bromocriptine
-Ropinirole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pkd drugs- mention 2 Monamine oxidase B(MAO-B) inhibitors

A

-Selegiline
-resagiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cathechol-o-methyl transferase inhibitors

A

Entacapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NMDA receptor blockers is ?

A

Amantadine

17
Q

Muscarinic Acetylcholine receptor antagonists

A

Orphenadrine
Procyclidine

18
Q

Pharmacokinetics of levodopa

A

*95% of levodopa is converted into dopamine in the intestine and can cause side effects only 5% gets into the brain

19
Q

Side effects of levodopa

A

-Dyskinesia (involuntary movement)
-Hypotension
-schizophrenic like syndrome like hallucinations,night mares ,insomnia
-nausea and anorexia

20
Q

Short notes on bromocriptide and why it was stopped

A

Bromocriptine, and cabergoline are dopamine agonists that are stopped due to side effects of fibrotic reactions in lungs , retroperitoneum and pericardium

21
Q

Side effects of dopamine angonists ropinirole include

A

-over eating
-gambling and excessive sexual behavior
-hallucinations and somnolence

22
Q

Good sides of dopamine agonists

A

-can improve mood
-have neurological protective activity
-D2/3 selective and better tolerated and do not show the fluctuations in efficacy

23
Q

Unwanted side effects of muscarinic antagonists

A

-dry mouth
-constipation
-urinary retention
-Mydiarisis
-Tachycardia

24
Q

Treatment of Parkinson’s disease and management which drug is contraindicated and what age?

A

-Patients age 65 we should not give muscarinic antagonist

25
Q

Patient with age 50-70 with moderate motor disorders which drugs can we start with

A

Agonist of dopamine plus inhibitor of MOA)B amantadine, or muscarinic antagonists for patients less than 65

26
Q

Age of patient 50-70 years with expressed motor and Cognitive Impairment which drugs should we administer

A

-start with levodopa
-if not improved add agonists of dopamine or inhibitor of MAO B or amantadine

27
Q

Describe pathogenesis Alzheimer’s disease

A

Brain shrinkage and loss of focal cholinergic neurons in basal forebrain and hippocampus

28
Q

Give 2 microscopic features of Alzheimer’s disease

A

-Amyloid plaques extra cellular deposits of Beta amyloid
-Intraneuronal neurofibrillary tangles (tau protein)

29
Q

Give 3 drugs for treatment of Alzheimer’s disease

A

1-choline alfascerate(precursor of acetylcholine)400 mg
2-Cholinesterase inhibitors: Rivastigmine
Donepezil
Galantamine
3 antiexitotoxic agent: Memantine